Archives by keyword

[, January 20, 2012]   A meeting of the minds in Minneapolis today aims, in part, to figure out what to do with the thousands of people in the US—about 79 000, according to St Jude Medical—who remain fitted with the company's "recalled" St Jude Medical Riata or Riata ST implantable cardioverter defibrillator (ICD) leads. There remains a lot of uncertainty about how to manage patients who have been implanted with Riata leads, whether or not they have shown signs of electrical abnormalities, according to Dr Robert G Hauser (Abbott Northwestern Hospital and Minneapolis Heart Institute, Minneapolis, MN), who along with Dr David L Hayes (Mayo Clinic, Rochester, MN) is directing today's meeting.
January 20, 2012
[Heartwire, May 25, 2010]   Researchers at the Minneapolis Heart Institute at Abbott Northwestern are excited about a small study known as the Steroid after Ablation (SAAB) trial, lead by Dr. Daniel Melby, a cardiologist with the Minneapolis Heart Institute at Abbott Northwestern. Interim results showed that steroid therapy following the ablation of atrial fibrillation (AF) resulted in a nonsignificant trend toward reduction of early AF symptoms.
May 25, 2010
[Heartwire, March 23, 2010]   Long-term marathon training and racing might not be as good for the heart as some runners think, a new study suggests. Researchers have shown that long-term marathon runners, those who have completed at least 25 marathons over the past 25 years, have increased coronary calcium and calcified plaque volume.
March 24, 2010